We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | NYSE:TEVA | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.11 | 0.85% | 12.99 | 13.03 | 12.78 | 12.94 | 8,982,074 | 01:00:00 |
From Apr 2019 to Apr 2024
By Josh Beckerman
Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) has reached a framework for a multistate settlement of opioid-related litigation, which would include donation of buprenorphine naloxone tablets with a value of about $23 billion (at wholesale acquisition cost).
Teva would also provide a cash payment of up to $250 million over 10 years.
Teva said an agreement in principle includes attorneys general from North Carolina, Pennsylvania, Tennessee and Texas, as well as certain defendants.
Attorneys said earlier Monday that Teva and three other companies agreed to a settlement with two Ohio counties.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
October 21, 2019 14:28 ET (18:28 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Teva Pharmaceutical Indu... Chart |
1 Month Teva Pharmaceutical Indu... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
